Abstract
The neural tissue is rich in polyunsaturated fatty acids (PUFAs), components that are indispensable for the proper functioning of neurons, such as neurotransmission. PUFA nutritional deficiency and imbalance have been linked to a variety of chronic brain disorders, including major depressive disorder (MDD), anxiety, and anorexia. However, the effects of PUFAs on brain disorders remain inconclusive, and the extent of their shared genetic determinants is largely unknown. Here, we used genome-wide association summary statistics to systematically examine the shared genetic basis between six phenotypes of circulating PUFAs (N = 114,999) and 20 brain disorders (N = 9,725-762,917), infer their potential causal relationships, identify colocalized regions, and pinpoint shared genetic variants. Genetic correlation and polygenic overlap analyses revealed a widespread shared genetic basis for 77 trait pairs between six PUFA phenotypes and 16 brain disorders. Two-sample Mendelian randomization analysis indicated potential causal relationships for 16 pairs of PUFAs and brain disorders, including alcohol consumption, bipolar disorder (BIP), and MDD. Colocalization analysis identified 40 shared loci (13 unique) among six PUFAs and ten brain disorders. Twenty-two unique variants were statistically inferred as candidate shared causal variants, including rs1260326 (GCKR), rs174564 (FADS2) and rs4818766 (ADARB1). These findings reveal a widespread shared genetic basis between PUFAs and brain disorders, pinpoint specific shared variants, and provide support for the potential effects of PUFAs on certain brain disorders, especially MDD, BIP, and alcohol consumption.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication was supported by the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number R35GM143060. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Co-first authors
Data Availability
All GWAS summary statistics are publicly available as described in the Methods section. All the code for this study was uploaded to GitHub for public access (https://github.com/Huifang-Xu/PUFA-BD).
Abbreviations
- 1KGP
- 1000 Genomes Project
- AD
- Alcohol dependence
- ADARB1
- Adenosine Deaminase RNA Specific B1
- ADHD
- Attention deficit-hyperactivity disorder
- ALZ
- Alzheimer’s disease
- AN
- Anorexia nervosa
- ANX
- Anxiety disorders and factors
- ASD
- Autism spectrum disorder
- AUDIT
- Alcohol use disorder identification test
- AUDIT_C
- AUDIT focusing on alcohol consumption
- AUDIT_P
- AUDIT focusing on the problematic consequences of drinking
- AUDIT_T
- AUDIT total score
- BIP
- Bipolar disorder
- cPUFA
- Circulating polyunsaturated fatty acids
- CS
- Credible set
- CUD
- Cannabis use disorder
- DHA
- Docosahexaenoic acid
- FADS
- Fatty acid desaturase
- GCKR
- Glucokinase regulatory protein
- GWAS
- Genome-wide association study
- h2
- Heritability
- INS
- Insomnia
- IVW
- Inverse weighted variance
- LA
- Linoleic acid
- LD
- Linkage disequilibrium
- LDSC
- LD Score regression
- MAF
- Minor allele frequency
- MDD
- Major depression
- MHC
- Major histocompatibility complex
- MOOD
- Mood disorders
- MR
- Mendelian randomization
- NAFLD
- Nonalcoholic fatty liver disease
- nc12
- Number of common variants shared between trait1 and trait2
- NE
- Neuroticism
- OCD
- Obsessive-compulsive disorder
- OD
- Opioid dependence
- PGC
- Psychiatric Genomic Consortium
- PP
- Posterior probability
- PTSD
- Post-traumatic stress disorder
- PUFA
- Polyunsaturated fatty acids
- rg
- Genetic correlation coefficient
- SCZ
- Schizophrenia
- SNP
- Single-nucleotide polymorphism
- TS
- Tourette syndrome
- VEP
- Variant Effect Predictor
